Latest News in the pharma Industry

Research & Development

Novartis drug Tasigna approved by FDA

Novartis drug Tasigna approved by FDA

28 Dec 2017

First and only CML therapy with Treatment-free Remission data in its label.

Read more 
MAA submitted to EMA for patisiran for the treatment of hereditary ATTR amyloidosis

MAA submitted to EMA for patisiran for the treatment of hereditary ATTR amyloidosis

27 Dec 2017

Sanofi and Alnylam's patisiran MAA to be reviewed under accelerated assessment.

Read more 
AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

27 Dec 2017

iMatrix recombinant Laminin-511 E8 protein fragments permit ES/iPS cells to be maintained in xeno-free, feeder-free culture conditions enabling easy application in medical trials.

Read more 
FiH trial of new immunotherapy approach shows efficacy in antibiotic resistance

FiH trial of new immunotherapy approach shows efficacy in antibiotic resistance

27 Dec 2017

Human polyclonal antibodies show promise as effective treatment.

Read more 
Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

21 Dec 2017

New collaboration agreement to identify new antisense oligonucleotide drug candidates.

Read more 
FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

19 Dec 2017

First and only FDA-cleared PK dosing software to support healthcare professionals in creating personalized dosing regimens for patients 16 and older with hemophilia A.

Read more 
Collaboration to develop innovative technologies

Collaboration to develop innovative technologies

20 Dec 2017

Project will innovate technologies in epigenetic characterisation for patient stratification in renowned precision medicine.

Read more 
NIH study uncovers clues about why common cancer drug causes hearing loss

NIH study uncovers clues about why common cancer drug causes hearing loss

20 Dec 2017

Researchers find target to protect hearing during chemotherapy treatment.

Read more 
Regeneron and ISA Pharma to advance immuno-oncology treatment

Regeneron and ISA Pharma to advance immuno-oncology treatment

18 Dec 2017

Collaboration to conduct clinical trials of the combination treatment in both cervical and head-and-neck cancer.

Read more 
Major breakthrough for new haemophilia A treatment

Major breakthrough for new haemophilia A treatment

15 Dec 2017

Drug trials provide mind-blowing results.

Read more 
New formulation of Oncaspar receives Marketing Authorization in Europe for patients with ALL

New formulation of Oncaspar receives Marketing Authorization in Europe for patients with ALL

14 Dec 2017

Freeze-dried, or lyophilized, formulation aims to improve supply management by providing the same dosing regimen as liquid Oncaspar but with a three-times longer shelf life of up to 24 months.

Read more 
CMC Biologics and Harpoon Therapeutics collaborate on exciting new TriTAC molecules

CMC Biologics and Harpoon Therapeutics collaborate on exciting new TriTAC molecules

14 Dec 2017

First clinical candidate, HPN424, is in development for the treatment of metastatic prostate cancer and expected to enter Phase I clinical trials in 2018.

Read more